ESTABLISHMENT LABS HOLDINGS INC. (ESTA) research
ESTABLISHMENT LABS HOLDINGS INC.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $64.06
- As of
ESTABLISHMENT LABS HOLDINGS INC. (ESTA): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
As of . Source: SEC EDGAR filings for ESTA. Method and limitations.
Share the ESTA intelligence card
See the full ESTA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ESTA on one page. Preview it with sample data, then open it live with a free account.
Preview the ESTA dossierActive signals for ESTA
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 77% of ESTA (2026Q2)
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 13.7%, EPS $-0.39 vs $-0.3431 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 29.7% - EPS $-0.38 vs $-0.5405 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 59.3% - EPS $-0.09 vs $-0.2211 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 26.9% - EPS $-0.45 vs $-0.3546 estimate
FREE, NO ACCOUNT
Every signal on ESTA, as it fires
New filings, 13F moves and cross asset signals on ESTA land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ESTA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP G31249108 · 2026Q2 | $48.6M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP G31249108 · 2026Q2 | $38.5M | 0.03% | , |
| CITADEL ADVISORS LLCCUSIP G31249108 · 2026Q2 | $8.7M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP G31249108 · 2026Q2 | $7.1M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ESTA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ESTA against its peers
ESTA's operating margin of -18.5% ranks in the 45th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | ESTA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 211M USD | 231M USD | 45 | 20 |
| Gross margin | 69.3% | 62.1% | 55 | 18 |
| Operating margin | -18.5% | -16.5% | 45 | 20 |
| Net margin | -24.2% | -13.6% | 40 | 20 |
| Return on equity | -216.9% | -11.8% | 2 | 20 |
| P / E | n/a | 34.4x | n/a | 5 |
Peers (20): UFPT, BFLY, AXGN, NEOG, IART, AVNS, AORT, ENOV, BBNX, CBLL, SIBN, INMD, QDEL, SSII, KIDS, DCTH, MASS, SENS, TCMD, NPCE. Left out: OSSUY (no annual filing), ALMR (no annual filing), NHNKF (no annual filing), LMRI (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (ESTA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ESTA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ESTAand get the insider, 13F, options, and confluence read in one view.